MedPath

Assessment of Efficacy & Safety of Topical & Intracameral application of combination of tropicamide, phenylephrine and lidocaine in phacoemulsification surgery a new approach..

Not Applicable
Conditions
Health Condition 1: H250- Age-related incipient cataractHealth Condition 2: H259- Unspecified age-related cataractHealth Condition 3: H259- Unspecified age-related cataract
Registration Number
CTRI/2021/08/035711
Lead Sponsor
Dr Dhruvil Nayak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients who have demonstrated, at a previous visit, a satisfactory pupil dilation ( >6mm) with topical mydriatic therapy.

All patients aged 40 to 70 years with senile cataract undergoing uncomplicated phacoemulsification surgery and willing to give written and informed consent for the study.

Uncomplicated Cataract

Cooperative patients

Exclusion Criteria

Patients having

Corneal pathology

Pupillary disorders

Retinal pathology

Increased intraocular pressure

p/h/o Psychiatric illness

uncontrolled Hypertension

h/o hypersensitivity to amide group of drugs

h/o ocular surgery

Pregnant patients

All the surgeries will be carried out under Stand by Anesthetic patients turning uncooperative will be given sedation and excluded from the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath